Nemaura Medical Stock Current Liabilities
| NMRDDelisted Stock | USD 0.93 0.01 1.06% |
Nemaura Medical fundamentals help investors to digest information that contributes to Nemaura Medical's financial success or failures. It also enables traders to predict the movement of Nemaura Pink Sheet. The fundamental analysis module provides a way to measure Nemaura Medical's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Nemaura Medical pink sheet.
Nemaura |
Nemaura Medical Company Current Liabilities Analysis
Nemaura Medical's Current Liabilities is the company's short term debt. This usually includes obligations that are due within the next 12 months or within one fiscal year. Current liabilities are very important in analyzing a company's financial health as it requires the company to convert some of its current assets into cash.
Current Nemaura Medical Current Liabilities | 658.01 K |
Most of Nemaura Medical's fundamental indicators, such as Current Liabilities, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Nemaura Medical is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Current liabilities appear on the company's balance sheet and include all short term debt accounts, accounts and notes payable, accrued liabilities as well as current payments due on the long-term loans. One of the most useful applications of Current Liabilities is the current ratio which is defined as current assets divided by its current liabilities. High current ratios mean that current assets are more than sufficient to pay off current liabilities.
CompetitionIn accordance with the recently published financial statements, Nemaura Medical has a Current Liabilities of 658.01 K. This is 99.96% lower than that of the Health Care Equipment & Supplies sector and 99.91% lower than that of the Health Care industry. The current liabilities for all United States stocks is 99.99% higher than that of the company.
Nemaura Current Liabilities Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Nemaura Medical's direct or indirect competition against its Current Liabilities to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Nemaura Medical could also be used in its relative valuation, which is a method of valuing Nemaura Medical by comparing valuation metrics of similar companies.Nemaura Medical is currently under evaluation in current liabilities category among its peers.
Nemaura Fundamentals
| Return On Equity | -7.24 | ||||
| Return On Asset | -0.49 | ||||
| Current Valuation | 22.58 M | ||||
| Shares Outstanding | 28.9 M | ||||
| Shares Owned By Insiders | 48.30 % | ||||
| Shares Owned By Institutions | 7.70 % | ||||
| Number Of Shares Shorted | 52.57 K | ||||
| Price To Earning | (707.14) X | ||||
| Price To Book | 122.56 X | ||||
| Price To Sales | 804.62 X | ||||
| Revenue | 77.04 K | ||||
| Gross Profit | (1.48 M) | ||||
| EBITDA | (8.17 M) | ||||
| Net Income | (14.14 M) | ||||
| Cash And Equivalents | 14.75 M | ||||
| Cash Per Share | 0.61 X | ||||
| Total Debt | 20.03 M | ||||
| Current Ratio | 0.99 X | ||||
| Book Value Per Share | (0.55) X | ||||
| Cash Flow From Operations | (8.45 M) | ||||
| Short Ratio | 0.30 X | ||||
| Earnings Per Share | (0.39) X | ||||
| Target Price | 3.5 | ||||
| Number Of Employees | 36 | ||||
| Beta | 0.046 | ||||
| Market Capitalization | 2.43 M | ||||
| Total Asset | 14.56 M | ||||
| Retained Earnings | (51.88 M) | ||||
| Working Capital | (8.73 M) | ||||
| Current Asset | 9.55 M | ||||
| Current Liabilities | 658.01 K | ||||
| Z Score | -7.48 | ||||
| Net Asset | 14.56 M |
About Nemaura Medical Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Nemaura Medical's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Nemaura Medical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Nemaura Medical based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.
Other Consideration for investing in Nemaura Pink Sheet
If you are still planning to invest in Nemaura Medical check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Nemaura Medical's history and understand the potential risks before investing.
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments |